CTT PHARMACEUTICAL HOLDINGS, INC.

CIK 1035422 · CEO · last filed 2025-12-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

0

Total Filings

50

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
No companies on record.

Recent Filings · Page 4 of 5

50 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-07-18 Buy (P) +1,800 $108
2024-07-15 Buy (P) +1,070 $64
2024-07-11 Buy (P) +2,730 $164
2024-07-05 Buy (P) +1,454 $87
2024-06-28 Buy (P) +1,300 $78
2024-06-24 Buy (P) +1,000 $70
2024-06-12 Grant (A) +86,956 $2.6K
2024-06-11 Buy (P) +1,990 $99
2024-06-03 Buy (P) +7,376 $148
2024-05-22 Buy (P) +3,236 $84
Showing 3140 of 50
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.